Integrins are a family of cell adhesion molecules (CAM's) that mediate
the communication between the intracellular and the extracellular com
partments. The growing interest in CAM's is due to the essential role
they play in cell-cell and cell-matrix recognition processes. These re
ceptors are formed by a non-covalently associated glycoprotein complex
of two distinct polypeptide chains, called, alpha and beta. The assoc
iation of different subunits results in the formation of, at least, 16
different integrins that provide cells with a great versatility in th
eir adhesion properties. An integrin molecule comprises a cytoplasmic
domain that interacts with the cytoskeleton, a transmembranous domain
and an extracellular domain that binds to one or more ligands. beta1,
beta2 and beta3, are the best characterized integrin subfamilies; they
are expressed, in different amounts, in epithelial and endothelial ce
lls, leukocytes, fibroblasts and platelets. b1 integrins are essential
ly involved in cell-extracellular matrix interactions and beta2 subfam
ily in leukocyte-leukocyte and leukocyte-endothelial cell communicatio
ns. The integrin subfamily beta3 mediates the adhesion of platelets wi
th fibrinogen and other ligands. During embryonic development, integri
ns in association with other CAM's, play an essential role in cell mig
ration and morphogenesis. Moreover, in processes like inflammation, wo
und healing and thrombosis, integrins and other CAM's mediate the inte
ractions among the injured tissue and circulating cells. In two geneti
c diseases like the leukocyte adhesion deficiency and the Glanzmann's
thrombasthenia an impairment in leukocyte-endothelial cell interaction
s and platelet aggregation is detected, due to deficiencies or abnorma
lities in beta2 or beta3 integrin subfamilies, respectively. In tumor
invasion and metastasis integrins are involved in processes like cell
detachment from extracellular matrix components, cell migration, homin
g and cell spreading. Integrins from beta1 and beta3 subfamilies also
mediate the interaction of tumor cells with platelets, facilitating th
e passage of neoplastic cells through the endothelium. Specific antibo
dies to integrins or soluble forms of these receptors or their ligands
could eventually be used for therapeutic purposes, modulating phenome
na like inflammation, thrombosis and tumor invasion.